AIM•benzinga•
AIM ImmunoTech Q1 2024 GAAP EPS $(0.12), Inline, Sales $40.000K Down From $49.000K YoY
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga